Ubi Pharma Inc is a Taiwan-based company mainly engaged in development and manufacturing of protein drugs and special dosage-form drugs. The Company is engaged in research and development, manufacturing and sales of protein drugs and special dosage-form drugs, contract manufacturing of pharmaceuticals, and provision of contract research services.

Employees

Sector

Pharmaceuticals

More about the company

End-of-day quote Taipei Exchange 06/05/2024			5-day change	1st Jan Change
14.25 ^TWD	+1.79%		-.--%	-

13/08	UBI Pharma Inc. Reports Earnings Results for the Half Year Ended June 30, 2026	CI
27/04	UBI Pharma Inc. Reports Earnings Results for the Full Year Ended December 31, 2025	CI

Market Cap	1.68B 53.16M 45.8M 42.95M 39.2M 73.85M 5.08B 74.09M 510M 199M 2.56B 200M 195M 8.5B	P/E 2024	-9.63x	P/E 2025	-5.68x
Enterprise Value	1.97B 62.28M 53.67M 50.32M 45.93M 86.53M 5.95B 86.8M 597M 233M 3B 234M 229M 9.96B	EV / Sales 2024	3.58x	EV / Sales 2025	3.83x
Free-Float	27.79%	Yield 2024 *	-	Yield 2025	-

13/08	UBI Pharma Inc. Reports Earnings Results for the Half Year Ended June 30, 2026	CI
27/04	UBI Pharma Inc. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
12/08/25	UBI Pharma Inc. Reports Earnings Results for the Half Year Ended June 30, 2025	CI
30/04/25	UBI Pharma Inc. Reports Earnings Results for the Full Year Ended December 31, 2024	CI
13/08/24	UBI Pharma Inc. Reports Earnings Results for the Half Year Ended June 30, 2024	CI
18/04/24	UBI Pharma Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
11/08/23	UBI Pharma Inc. Reports Earnings Results for the Half Year Ended June 30, 2023	CI
21/04/23	UBI Pharma Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	CI
15/08/22	UBI Pharma Inc. Reports Earnings Results for the Half Year Ended June 30, 2022	CI
29/04/22	UBI Pharma Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	CI
29/04/22	UBI Pharma Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	CI
16/08/21	Medigen Vaccine Biologics : Taiwan rejects COVID vaccine candidate, president to get domestic shot	RE
16/08/21	Medigen Vaccine Biologics : Taiwan denies approval for UBI's COVID-19 vaccine candidate	RE

3 years	10	38.5
5 years	10	139.55
10 years	8.34	288.72

UBI Pharma Inc. Stock

Stocks

6562

TW0006562002

Pharmaceuticals

Valuation : UBI Pharma Inc.

Latest news : UBI Pharma Inc.

Quotes and Performance

Price Extremes

Managers and Directors : UBI Pharma Inc.

Other Pharmaceuticals

Financials

Company Profile

Manager	Title	Age	Since
Jung Kuang Yang CEO	Chief Executive Officer	-	-
Meng Han Hsu DFI	Director of Finance/CFO	-	11/04/2016
Ying Yun Fan ADM	Chief Administrative Officer	-	01/03/2015

Director	Title	Age	Since
Ying Yun Fan BRD	Director/Board Member	-	30/06/2020
Yan Ning Kuo BRD	Director/Board Member	-	30/06/2020
Yao Hui Wei BRD	Director/Board Member	-	30/06/2020

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
UBI PHARMA INC.	+1.79%	-.--%	-.--%	-55.47%	53.12M
ELI LILLY AND COMPANY	-0.13%	-5.61%	+59.99%	+112.16%	1,048B
JOHNSON & JOHNSON	+0.85%	+0.25%	+51.61%	+61.23%	640B
ABBVIE INC.	-1.03%	-2.43%	+22.79%	+74.16%	456B
ROCHE HOLDING AG	-1.46%	-3.52%	+36.60%	+38.39%	362B
NOVARTIS AG	-0.72%	-2.06%	+21.34%	+37.92%	295B
ASTRAZENECA PLC	-1.19%	-0.98%	+0.79%	+12.29%	255B
AMGEN INC.	-1.05%	-0.30%	+50.16%	+68.66%	236B
NOVO NORDISK A/S	+0.08%	-0.22%	-17.16%	-53.76%	204B
GILEAD SCIENCES, INC.	-2.14%	+1.56%	+27.88%	+89.54%	185B
Average	-0.41%	-0.21%	+25.40%	+38.51%	368.17B
Weighted average by Cap.	-0.42%	-1.92%	+37.92%	+65.36%

	2024	2025
Net sales	539M 17.02M 14.66M 13.75M 12.55M 23.64M 1.63B 23.72M 163M 63.64M 821M 63.89M 62.5M 2.72B	514M 16.25M 14M 13.13M 11.98M 22.57M 1.55B 22.64M 156M 60.76M 784M 60.99M 59.67M 2.6B
Net income	-175M -5.51M -4.75M -4.45M -4.06M -7.66M -527M -7.68M -52.83M -20.61M -266M -20.69M -20.24M -882M	-296M -9.36M -8.06M -7.56M -6.9M -13M -894M -13.04M -89.69M -34.99M -451M -35.13M -34.36M -1.5B
Net Debt	246M 7.78M 6.7M 6.29M 5.74M 10.81M 744M 10.84M 74.57M 29.1M 375M 29.21M 28.57M 1.24B	289M 9.12M 7.86M 7.37M 6.73M 12.68M 872M 12.72M 87.45M 34.12M 440M 34.25M 33.51M 1.46B